Parallax Volatility Advisers, L.P. Mersana Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$16.84 - $27.59 $483,392 - $791,970	-28,705 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$16.2 - $25.7 $465,021 - $737,718	28,705 New	28,705 $534,000
Q1 2018 May 15, 2018	SELL	$13.56 - $18.48 $10,251 - $13,970	-756 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$14.95 - $19.9 $11,302 - $15,044	756	756 $12,000

123

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $60.2M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.